New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
13:46 EDTOPXAOpexa Therapeutics held a conference call
Conference call to discuss the option and license agreement with Merck Serono for development of Tcelna for treatment of Multiple Sclerosis was held on February 5 at 8:30 am and has a webcasted replay available. Webcast Link
News For OPXA From The Last 14 Days
Check below for free stories on OPXA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
11:23 EDTOPXAOpexa Therapeutics mentioned positively by Seeking Alpha contributor
Subscribe for More Information
September 16, 2014
08:34 EDTOPXAOpexa Therapeutics terminates public offering of common stock
Opexa Therapeutics announced that it has terminated the public offering of shares of its common stock previously announced on Monday, September 15. The termination results from an assessment by Opexa’s management that current market conditions are not conducive for an offering on terms that would be in the best interests of Opexa’s stockholders. As a result of such termination, no shares will be sold pursuant to the offering.
September 15, 2014
16:22 EDTOPXAOpexa Therapeutics files automatic common stock shelf
Aegis Capital Corp. is acting as sole book-running manager in this offering.
September 8, 2014
07:30 EDTOPXAOpexa Therapeutics to target NMO as next development program
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use